bioRxivPathology
Ferrochelatase regulates retinal neovascularization
Abstract
Ferrochelatase (FECH) is the terminal enzyme in heme biosynthesis. We previously showed that FECH is required for endothelial cell growth in vitro and choroidal neovascularization in vivo. But FECH has not been explored in retinal neovascularization, which underlies diseases like proliferative diabetic retinopathy and retinopathy of prematurity. Here, we investigated the inhibition of FECH using genetic and chemical approaches in the oxygen-induced retinopathy (OIR) mouse model. In OIR mice, FECH expression is upregulated and co-localized with neovascular tufts. Partial loss-of-function Fechm1Pas mutant mice showed reduced retinal neovascularization and endothelial cell proliferation in OIR. An intravitreal injection of the FECH inhibitor N-methyl protoporphyrin had similar effects. Griseofulvin is an anti-fungal drug that inhibits FECH as an off-target effect. Strikingly, intravitreal griseofulvin blocked pathological tuft formation and revascularized areas of vasoobliteration faster than vehicle, suggesting potential as a FECH-targeting therapy. Ocular toxicity studies revealed that intravitreal injection of griseofulvin in adult mice does not disrupt retinal vasculature, function, or morphology. In sum, mutation and chemical inhibition of Fech reduces retinal neovascularization and promotes physiological angiogenesis, suggesting a dual effect on vascular repair upon FECH inhibition, without ocular toxicity. These findings suggest that FECH inhibitors could be repurposed to treat retinal neovascularization.Competing Interest StatementS. Pran Babu and T. W. Corson are named inventors on patent applications related to this work.AbbreviationsBSAbovine serum albuminDAIdays after injectionDMSOdimethyl sulfoxideEdU5-ethynyl-2′-deoxyuridine (EdU)ERGelectroretinogrameNOSendothelial nitric oxide synthaseEPPerythropoietic protoporphyriaETCelectron transport chainFAfluorescein angiographyFECHferrochelataseGCLganglion cell layerGFAPglial fibrillary acidic proteinGS-IB4Griffonia simplicifolia isolectin B4H&Ehematoxylin and eosinHIF-1hypoxia inducible factor 1HO-1heme oxygenase 1INLinner nuclear layerNMPPN-methyl protoporphyrinOCToptical coherence tomographyOIRoxygen induced retinopathyONLouter nuclear layerPBSphosphate buffered salinePDRproliferative diabetic retinopathyPFAparaformaldehydePPIXprotoporphyrin IXROPretinopathy of prematurityVEGFvascular endothelial growth factorView Full Text
- organism: mouse
- research focus: host-pathogen & immune response
- research focus: cell signaling & trafficking
- research focus: development & morphogenesis
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeting endothelial ERG to mitigate vascular regression and neuronal ischemia in retinopathies
Eric Ma, Christopher M. Schafer, … Courtney T. Griffin·Proceedings of the National Academy of SciencesPeer-reviewed·Sep 23, 2025
- CYP46A1 Activation Improves Retinal Neovascularization in a Mouse Model of Retinopathy of Prematurity
Briah Bailey, Josephine Rudd Zhong Manis, … Menaka Chanu Thounaojam·bioRxiv·Oct 14, 2025
- Loss of Farnesoid X Receptor Signaling Promotes Choroidal Neovascularization in Mice
Chanel Harris, Mohammed A Nisar, … Menaka Chanu Thounaojam·bioRxiv·Oct 23, 2026
- eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin
T. Ninchoji, D. T. Love, … L. Claesson-Welsh·bioRxiv·Nov 24, 2020
- Heme synthesis inhibition blocks angiogenesis via mitochondrial dysfunction
T. Shetty, K. Sishtla, … T. W. Corson·bioRxiv·Nov 9, 2019
- Photoreceptor-derived FGF2 mediates a protective stress response without driving pathological retinal neovascularization in ischemic retinopathy